Diaceutics Fusion™ is a proprietary, web-based, software application that provides a range of business intelligence and performance management applications used for personalized medicine planning, collaboration and decision-making. Utilizing easy to navigate route maps and an intuitive user interface, the software incorporates the six years of research, case studies, worktools, data sets, financial models and expertise that Diaceutics have built around the co-development and commercialization of companion and other diagnostic tests. Diaceutics Fusion™ standardizes the planning, analytical, decision and action steps needed to align the co-development and successful commercialization of companion and other diagnostics.

Diaceutics Fusion™ is much more than a simple project management tool or a knowledge database – it directly plugs the power of Diaceutics experience into the hands of the pharmaceutical client and allows deployment on a number of levels:

  • Provides personalized medicine leaders a tangible resource to provide therapy area leads and asset development teams seeking insight, expertise and best practices to guide their personalized medicine planning;

  • Allows asset development teams to effortlessly work through the 11 key frameworks and decisions underpinning the additional 250 workstreams necessary to align co-development and commercialization of companion and other diagnostics.

  • Provides the ability to revisit and, where necessary, reconsider and revise decisions, while at the same time immediately capturing and incorporating those new decisions into the existing plans for seamless, iterative planning;

  • Creates a foundation upon which corporate knowledge of best practices and decisions in personalized medicine planning may be captured, stored and disseminated in order to build corporate knowledge and internal expertise around personalized medicine planning.

To learn more about the specific products offered in Diaceutics Fusion™, click on any of the subtabs above.

To learn more about how Diaceutics Fusion™ can be customized for your needs, click here.



*Roger Schank President/CEO, Socratic Arts Former Director, Yale Artificial Intelligence Project Founder, Institute of Learning Sciences, Northwestern University Co-Founder, Center for the Learning Sciences, Carnegie Mellon University